查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602383

主動式植入式醫療設備市場：按產品類型、植入類型和最終用戶分類 - 2025-2030 年全球預測

Active Implantable Medical Devices Market by Product (Cochlear Implants, Haemodynamic Support, Implantable Cardiac Pacemakers), Implant Type (Complete implantable, Partial implantable), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

有源植入式醫療設備市場2023年估值為26.5億美元，預計2024年將達29.1億美元，複合年成長率為9.92%，2030年將達51.4億美元。

主動植入式醫療設備(AIMD) 是透過手術或醫學方式永久植入人體並在治療嚴重醫療狀況後保留在體內的裝置。包括心律調節器、心臟去顫器、神經刺激設備和人工電子耳等設備。這些設備對於緩解症狀和恢復身體功能對於慢性病患者至關重要。心血管疾病、神經系統疾病和聽力障礙盛行率的增加是市場需求的主要驅動力。此外，醫療保健支出的增加、醫療技術的進步和人口老化也對市場擴張做出了重大貢獻。目前的技術創新，例如小型化、無線技術和改進的生物相容性，提供了充滿希望的機會。鼓勵公司投資研發，專注於開發可延長電池壽命並降低感染風險的多功能設備。儘管前景樂觀，但嚴格的監管要求、高昂的開拓成本以及設備故障引起的併發症等挑戰正在限制市場成長。為了緩解這些障礙，必須認真對待合規和風險管理框架。此外，各國複雜的報銷制度也加劇了市場緊張。然而，整合遠端醫療整合和遠端監控功能等數位健康應用程式可以為您的業務帶來顯著的效益。此外，探索個人化醫療也具有潛力，即根據基因圖譜和特定患者需求客製化設備。由於醫療基礎設施不發達和患者群龐大，新興市場提供了開拓的商機。您還可以透過與醫療保健提供者建立策略夥伴關係關係並專注於 AIMD 的教育舉措來提高市場滲透率。簡而言之，透過創新、適應性和策略夥伴關係關係的正確結合，AIMD 市場的成長時機已經成熟，但必須謹慎應對監管和財務限制。

主要市場統計
基準年[2023] 26.5億美元
預測年份 [2024] 29.1億美元
預測年份 [2030] 51.4億美元
複合年成長率（%） 9.92%

市場動態：快速發展的主動植入醫療設備市場的關鍵市場洞察

有源植入式醫療設備市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 心血管疾病盛行率上升
    • 神經系統疾病患者增加
    • 提高神經刺激設備的認知與傳播
  • 市場限制因素
    • 與植入式醫療設備相關的不良健康影響
  • 市場機會
    • 下一代IMD中運算和通訊功能的整合
    • 先進醫療設備領域研發投入快速增加
  • 市場挑戰
    • 對高成本和嚴格的許可規定的擔憂

波特五力：駕馭主動植入醫療設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解有源植入醫療設備市場的外部影響

外部宏觀環境因素在塑造主動植入醫療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解主動式植入醫療設備市場的競爭格局

有源植入式醫療設備市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣主動式植入醫療設備市場供應商的績效評估

FPNV 定位矩陣是評估主動式植入醫療設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，為主動植入式醫療設備市場的成功指明道路

對於旨在加強其在全球市場的影響力的公司來說，有源植入式醫療設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病盛行率上升
      • 神經系統疾病患者增加
      • 提高神經刺激設備的認知與採用
    • 抑制因素
      • 植入式醫療設備對健康的不良影響
    • 機會
      • 下一代IMD中運算和通訊功能的整合
      • 先進醫療設備領域研發投入快速增加
    • 任務
      • 對高成本和嚴格許可規定的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章主動置入醫療設備市場：依產品

  • 人工電子耳
  • 血流動力學支持
  • 植入式心臟心律調節器
  • 植入式心臟整流去顫器
  • 植入式血糖監測儀
  • 植入式輸液幫浦及配件
  • 植入式監測裝置
  • 植入式神經刺激系統
  • 輔助人工心臟

第 7 章依植入類型分類的主動植入醫療設備市場

  • 完整植入
  • 部分嵌入型

第8章活躍的植入式醫療設備市場：依最終用戶分類

  • 門診中心
  • 心臟中心
  • 牙醫診所
  • 醫院

第9章美洲活躍的植入式醫療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太有源植入醫療設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲活躍的植入式醫療設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Abbott Laboratories
  • Aleva Neurotherapeutics
  • Allergan Inc. by AbbVie Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • CONMED Corporation
  • Definitive Healthcare, LLC
  • Demant A/S
  • Dentsply Sirona Inc.
  • Globus Medical, Inc.
  • GMED
  • Integra Lifesciences Holdings Corporation
  • Invibio Ltd.
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • NuVasive, Inc.
  • Smith & Nephew PLC
  • Sonova Holding AG
  • Straumann AG
  • Stryker Corporation
  • TUV Rheinland AG
  • Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
  • Zimmer Biomet
Product Code: MRR-4369010661A4

The Active Implantable Medical Devices Market was valued at USD 2.65 billion in 2023, expected to reach USD 2.91 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 5.14 billion by 2030.

Active Implantable Medical Devices (AIMDs) refer to instruments intended to be introduced fully, surgically, or medically into the human body, and stay there post-procedure, to manage severe medical conditions. They encompass devices like pacemakers, defibrillators, neurostimulators, and cochlear implants. These devices are crucial for patients with chronic conditions by alleviating symptoms or restoring bodily functions. The growing prevalence of cardiovascular diseases, neurological disorders, and hearing impairments are key drivers of market demand. Additionally, increasing healthcare spending, advancements in medical technologies, and aging populations contribute significantly to market expansion. Current innovations, such as miniaturization, wireless technologies, and improved biocompatibility, present promising opportunities. Companies are encouraged to invest in R&D, focusing on creating multifunctional devices with enhanced battery life and reduced risk of infection. Despite the optimism, challenges such as stringent regulatory requirements, high costs of development, and complications arising from device failure limit market growth. The necessity for diligent compliance and risk management frameworks is crucial to mitigate such hindrances. The complex reimbursement landscapes in different countries further add to market strain. However, embracing digital health applications, such as telemedicine integration and remote monitoring capabilities, can provide significant business advantages. Furthermore, there is potential in exploring personalized medicine to customize devices based on genetic profiles and specific patient needs. Emerging markets present untapped opportunities due to inadequate healthcare infrastructure and the availability of a large patient pool. Engaging in strategic partnerships with healthcare providers and focusing on educational initiatives about AIMDs can also boost market penetration. In essence, the AIMD market is ripe for growth with the right blend of innovation, adaptability, and strategic partnerships, although careful navigation of regulatory and financial constraints is necessary.

KEY MARKET STATISTICS
Base Year [2023] USD 2.65 billion
Estimated Year [2024] USD 2.91 billion
Forecast Year [2030] USD 5.14 billion
CAGR (%) 9.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Active Implantable Medical Devices Market

The Active Implantable Medical Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiovascular diseases
    • Growing number of patients with neurological disorders
    • Increase in awareness and adoption of neurostimulator devices
  • Market Restraints
    • Associated adverse health impacts of implantable medical devices
  • Market Opportunities
    • Integration of computing and communication capabilities in next generation IMDs
    • Surging R&D investment in field of advanced medical devices
  • Market Challenges
    • Concern regarding high cost and stringent regulations for approval

Porter's Five Forces: A Strategic Tool for Navigating the Active Implantable Medical Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Active Implantable Medical Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Active Implantable Medical Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Active Implantable Medical Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Active Implantable Medical Devices Market

A detailed market share analysis in the Active Implantable Medical Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Active Implantable Medical Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Active Implantable Medical Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Active Implantable Medical Devices Market

A strategic analysis of the Active Implantable Medical Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Active Implantable Medical Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Aleva Neurotherapeutics, Allergan Inc. by AbbVie Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cochlear Ltd., CONMED Corporation, Definitive Healthcare, LLC, Demant A/S, Dentsply Sirona Inc., Globus Medical, Inc., GMED, Integra Lifesciences Holdings Corporation, Invibio Ltd., Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, NuVasive, Inc., Smith & Nephew PLC, Sonova Holding AG, Straumann AG, Stryker Corporation, TUV Rheinland AG, Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Active Implantable Medical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cochlear Implants, Haemodynamic Support, Implantable Cardiac Pacemakers, Implantable Defibrillators, Implantable Glucose Monitors, Implantable Infusion Pumps & Accessories, Implantable Monitoring Devices, Implantable Neuro Stimulator Systems, and Ventricular Assist Devices.
  • Based on Implant Type, market is studied across Complete implantable and Partial implantable.
  • Based on End-User, market is studied across Ambulatory Centers, Cardiac Centers, Dental Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiovascular diseases
      • 5.1.1.2. Growing number of patients with neurological disorders
      • 5.1.1.3. Increase in awareness and adoption of neurostimulator devices
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse health impacts of implantable medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of computing and communication capabilities in next generation IMDs
      • 5.1.3.2. Surging R&D investment in field of advanced medical devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding high cost and stringent regulations for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Active Implantable Medical Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cochlear Implants
  • 6.3. Haemodynamic Support
  • 6.4. Implantable Cardiac Pacemakers
  • 6.5. Implantable Defibrillators
  • 6.6. Implantable Glucose Monitors
  • 6.7. Implantable Infusion Pumps & Accessories
  • 6.8. Implantable Monitoring Devices
  • 6.9. Implantable Neuro Stimulator Systems
  • 6.10. Ventricular Assist Devices

7. Active Implantable Medical Devices Market, by Implant Type

  • 7.1. Introduction
  • 7.2. Complete implantable
  • 7.3. Partial implantable

8. Active Implantable Medical Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Centers
  • 8.3. Cardiac Centers
  • 8.4. Dental Clinics
  • 8.5. Hospitals

9. Americas Active Implantable Medical Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Active Implantable Medical Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Active Implantable Medical Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Aleva Neurotherapeutics
  • 4. Allergan Inc. by AbbVie Inc.
  • 5. BIOTRONIK SE & Co. KG
  • 6. Boston Scientific Corporation
  • 7. Cochlear Ltd.
  • 8. CONMED Corporation
  • 9. Definitive Healthcare, LLC
  • 10. Demant A/S
  • 11. Dentsply Sirona Inc.
  • 12. Globus Medical, Inc.
  • 13. GMED
  • 14. Integra Lifesciences Holdings Corporation
  • 15. Invibio Ltd.
  • 16. Johnson & Johnson Services, Inc.
  • 17. LivaNova PLC
  • 18. Medtronic PLC
  • 19. Microport Scientific Corporation
  • 20. NuVasive, Inc.
  • 21. Smith & Nephew PLC
  • 22. Sonova Holding AG
  • 23. Straumann AG
  • 24. Stryker Corporation
  • 25. TUV Rheinland AG
  • 26. Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
  • 27. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HAEMODYNAMIC SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE NEURO STIMULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COMPLETE IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PARTIAL IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023